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IT has previously been shown that fortnightly skin paintings ofan oily solution
of dimethylbenzanthracene (DMB) induce a high incidence of granulosa-celled
tumours ofthe ovary, as well as ofbreast tumours, in mice ofthe IF strain and its
first generation hybrids (Howell, Marchant and Orr, 1954; Marchant, 1957). The
earliest ovarian tumour was encountered after 4 months of treatment.
In a subsequent experiment ovaries from F1 C57B1 X IF mice, which had been
treated with DMB for 3 months, were transplanted bilaterally to the ovarian
capsules ofuntreated mice. In 14 out of 18 ofthese animals large ovarian tumours
were found 15 months later, many ofthem beingluteinised (Marchant, 1959a). At
the same time a preliminary account was given ofthe incidence ofovarian tumour
nodules found in a series of DMB-treated mice killed at monthly intervals after
beginning the treatment, for it was important to know whether or not incipient
tumours were already present in the transplanted ovaries.
The present report gives further details of this attempt to discover at what
stage inDMB treatment tumournodules first appeared in the ovaries. It describes
the histological changes that preceded the appearance ofgranulosa-celled tumours,
as well as those that occurred simultaneously in non-tumourous ovaries. It also
gives observations on the luteinisation of established granulosa-celled tumours,
which was not seen in mice of the IF strain or C57 B1 strain reported previously
(Marchant, 1957). Finally, it reports the incidence and histology of the palpable
breast tumours which appeared after the 4th month of the experiment.
MATERIALS AND METHOD
Eighty-five virgin female mice lacking the mammary tumour agent were used
in this experiment. They were F1 hybrids derived from C57 B1 mothers and IF
fathers. Theywere housed 5 in a box andfed onrat cubes known as the Thompson
diet.
When the mice were between 2 and 4 months old, fortnightly skin paintings
of0.5 per cent DMB in olive oil were commenced. Up to 6 treatments were given,
each mouse receiving about 0.2 ml. (1 mg.) distributed in 16 spots over dorsal and
ventral surfaces at each painting.
Ten mice were killed at monthly intervals at the beginning of the experiment.
After the 4th month breast tumours made their appearance, growing rapidly and
necessitating the killing of some animals at irregular times. On account of this,OVARIES OF MICE TREATED WITH DIMETHYLBENZANTHRACENE 653
the results reported below include some mice which had to be killed within 2 weeks
of the specified month.
For a short while before death, vaginal smears were taken from nearly all
the mice surviving 4 months or more, to determine whether the ovaries were
secreting oestrogen or not.
At autopsy the mice were examined for palpable breast tumours, many of
which were removed for histological examination. All ovaries were examined
and removed. Those from mice up to and including the 5th month of treatment
were serially sectioned. After that time representative sections from several
different levels were mounted. Sections were stained with haematoxylin and
eosin.
The ovaries of 5 untreated mice aged 6 months were also examined and serially
sectioned.
In the early stages follicles and corpora lutea in the largest sections from each
ovary were counted under low power to give a rough quantitative estimate of
changes.
RESULTS
Ovaries
Untreated mice.-The ovaries of the 5 untreated mice, which were 6 months
old, were about 3 x 4 mm. in diameter, roughlykidney-shaped, coloured pale pink
and studded with bright pink, white or pale yellow spots.
In histological sections, numerous follicles and corpora lutea were seen,
bounded by a stroma of fibrous and vascular tissue (Fig. 1). The follicles occa-
sionally contained 2 oocytes. They, together with the corpora lutea, were situated
towards the periphery. A few tiny clusters oflipochrome cells were seen. The
largest sections from each of the 10 ovaries were examined in detail. They con-
tained from 12 to 22 follicles withgranulosa-cells (mean 15.8) and 13-27 fragments
of corpora lutea (mean 19-4) per section.
One month DMB treatment.-After 1 month of DMB treatment (2 fortnightly
paintings) the ovaries of the 10 mice examined appeared similar to those of
untreated animals.
Histologically, too, there was little difference from normal. The largest
sections, however, contained slightly fewer follicles and corpora lutea. The
follicles numbered 5-19 (mean 12.7) and the corpora lutea 9-24 (mean 17.5). In
4 ofthe animals a few ofthe corpora lutea appeared to be merging.
Two months DMB treatment.-After 2 months of DMB treatment the ovaries
of the 10 mice killed appeared macroscopically normal. In histological sections,
a slight increase in numbers of merging corpora lutea was seen and the numbers
of follicles counted in the largest sections of each ovary had fallen considerably.
The follicles numbered 0-8 (mean 3) and the numbers of individual corpora lutea
were 8-23 (mean 15.5).
Three months DMB treatment.-After 3 months of DMB treatment (6 fort-
nightly paintings) only 1 mouse of the 10 killed had what appeared to be normal
ovaries macroscopically. The other ovaries in the group were atrophied, fairly
smooth and yellowish.
All 20 ovaries were very abnormal histologically (Fig. 2). In the largest
sections no follicles were found, but examination ofall the serial sections revealedJUNE MARCHANT
1 graafian follicle in 1 ovary of 4 different mice, and a 5th mouse had 3 graafian
follicles in 1 ovary. Fusion of corpora lutea was much more marked in this
group of animals and in 7 ovaries no distinct corpora were found. The ovaries
of the mouse, which had appeared to be normal macroscopically, showed the
least degree of fusion of corpora. In 1 mouse, in which no follicles were found
and fusion of corpora lutea was well advanced, a nodule of tissue resembling
granulosa-celled tumour was found, similar in size to a ripe follicle or corpus
luteum. It is considered that this was the earliest certain tumour nodule found
in this experiment. Four ovaries with fused corpora lutea contained tiny cysts.
Four months from 1st DMB treatment.-After 4 months of DMB treatment
(6 fortnightly paintings) all the 10 mice killed had abnormal ovaries. In 3 mice
the 2 ovaries were unequal in size, 1 ovary being about normal in size, the other
slightly atrophied, yellowish and smooth. In the larger ovaries of these 3 mice
small granulosa-celled tumours were found, the largest being nearly 2 mm.
diameter and making up about half the volume of the ovary. These small
tumours were relativelyundifferentiated orshowedpseudofollicular differentiation.
One was made up of 2 small nodules, 1 of which is illustrated in Fig. 4 and 5.
Vaginal smears ofall 3 mice showed predominantly oestrus smears about the time
of death.
In the other 7 mice, both ovaries were slightly atrophied, yellowish and
smooth. Histologically these ovaries showed a complete absence of follicles and
oocytes from all sections. Corpora lutea were rarely distinct bodies and most of
them were fused into masses of lutein tissue. From this time onwards consider-
able variation began to occur in the types of cells comprising the lutein tissue.
Sometimes the cells were vacuolated or pigmented and in some cases the lutein
tissue was converted in part to collagenous tissue, resembling human corpora
albicantia. This condition has been referred to as "hyalinised" (Fekete, 1946;
Atkinson, Dickie and Fekete, 1954). Vaginal smears showed predominantly
dioestrus smears in 3 mice and anoestrus smears in the others. In one of the
former, a tiny nodule suspected of being an incipient tumour was found.
Five months from 1st DMB treatment.-Fourteen mice were killed about 5
months from the 1st DMB treatment, 10 of which had palpable breast tumours.
Macroscopically their ovaries were more variable than at 4 months. One had a
dark red lump about 13 mm. in diameter in 1 ovary, which proved to be a blood
clot on histological examination.
Another mouse had an enlarged ovary, about 5 mm. diameter, divided into 2
separate lobes. One lobe was pink and this proved to be a granulosa-celled
tumour which was slightly luteinised. The other lobe, like the contralateral
ovary, was very pale yellow and knobbly. This mouse had predominantly di-
oestrus vaginal smears.
Four mice had ovaries unequal in size, the larger in each case proving to con-
tain a small granulosa-celled tumour. Three of these had oestrus smears and 1
had anoestrus smears.
One mouse had smooth, pale pink ovaries, about normal in size, which were
found to be invaded by lymphocytes. This mouse had a thymic tumour and
generalised lymphomatosis, a condition found in about 20 per cent of the mice
killed from 5 months onwards.
The other 8 mice in this group had atrophied ovaries which were pale yellowish
colour and smooth or knobbly. Like non-tumourous parts oftumourous ovaries,
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on histological examination they showed diffuse luteinisation (Fig. 3) with varying
degrees of hyalinisation, the knobbly ovaries being the most hyalinised. There
was a complete lack of follicles, occasional small clumps of pigmented cells or
scattered mast cells. Two ofthese mice had ovaries containing small granulosa-
celled tumours and they had predominantly oestrus smears. Two others had
suspected tumour nodules in them, 1 having dioestrus and the other anoestrus
smears (Fig. 7 and 8). The other 4 mice with atrophied ovaries had anoestrus
smears.
Six monthsfrom 1st DMB treatment.-Eleven mice were killed about 6 months
from the 1st DMB treatment, 9 ofthem having palpable breast tumours.
One of these mice had a cyst 5 mm. in diameter in 1 ovary. It was filled
with clear fluid and in its walls the ovarian tissue was embedded. This was
found to be a luteinised tumour. The mouse had anoestrus smears.
Another mouse had ovaries unequal in size, the larger containing a small
granulosa-celled tumour, the vaginal smears being oestrus.
A third mouse had ovaries about normal in size, pale yellow and studded with
white spots. This appearance was due to very marked hyalinisation of corpora
lutea. A small luteinising tumour was found in 1 ovary and the vaginal smears
were predominantly oestrus.
The other 8 mice had smooth, yellowish atrophied ovaries. A small granulosa-
celled tumour was found in 1 of them and another had a suspected tumour and
oestrus smears. The remainder had diffusely luteinised ovaries with, on the
whole, a greater degree of hyalinisation then after 5 months and an increased
number of mast cells present. They had anoestrus smears, with the exception
of 1 mouse which had predominantly oestrus smears and whose ovaries were
almost completely hyalinised.
Seven months from 1st DMB treatment.-Fourteen mice were killed about 7
months after the 1st DMB treatment, 13 of these having palpable breast tumours.
One mouse had a purple lump about 9 mm. diameter in 1 ovary, which proved
to be a blood clot. The other ovary was atrophied and was found to be com-
pletely invaded by lymphocytes.
Another mouse had in 1 ovary a cyst about 8 mm. diameter filled with clear
fluid and a luteinised tumour was embedded in its walls. It had anoestrus
vaginal smears.
Five mice had 1 enlarged ovary measuring between 4 and 8 mm. diameter.
All of these contained granulosa-celled tumours and in 2 there were signs of
luteinisation of the tumours. Four of the 5 mice had predominantly oestrus
smears and the other had anoestrus smears.
Five mice had unequal but un-enlarged ovaries, the smaller being atrophied.
The larger ovary of 1 of these proved to be a blood-filled cyst, but the oontra-
lateral atrophied ovary contained a small granulosa-celled tumour. This mouse
had oestrus smears. Another had both ovaries very heavily invaded by lympho-
cytes and its vaginal smears were oestrus. The bigger ovary may well have con-
tained a tumour but it was impossible to be certain because of the lymphocytic
infiltration. It is therefore scored as a suspected tumour. In the other 3 mice
with unequal ovaries a small granulosa-celled tumour, was found in the larger
ovary. In 1 case it was partly luteinised (Fig. 9 and 10). One of these mice
also had a small tumour in the smaller ovary. This mouse had anoestrus smears
and the other 2 had oestrus smears.JUNE MARCHANT
The remaining 2 mice had atrophied ovaries and 1 contained a small cyst lined
by ciliated epithelium. Both had anoestrus smears. All atrophied ovaries were
diffusely luteinised and hyalinised to varying degrees (Fig. 4). Mast cells were
frequently present, as were patches of large pigmented cells.
Eight months from 1st DMB treatment.-Six mice survived 8 months from the
first DMB treatment, all developing breast tumours.
A solid yellow tumour about 9 mm. diameter was found in 1 mouse. It was
a pseudofollicular granulosa-celled tumour, showing all stages of luteinisation
(Fig. 11 and 12). Vaginal smears were oestrus.
Another mouse had unequal ovaries, the larger being divided into a yellow
and a dark red lobe, each about 3 mm. diameter. The dark red lobe, contained
a slightly luteinised granulosa-celled tumour, and blood-filled cyst. This mouse
had anoestrus smears.
A 3rd mouse had both ovaries slightly enlarged-about 4 to 5 mm. diameter.
One was red and yellow and enclosed in a small cyst filled with clear fluid and the
red part proved to be a blood-filled cyst. The other was yellow in colour and
EXPLANATION OF PLATES
All figures show sections of ovaries of F1 C57 B1 x IF mice treated fortnightly with dimethyl-
benzanthracene (DMB). Haematoxylin and eosin stained.
Fig. 1 to 4 show non-tumourous ovaries.
FIG. 1. Ovary of untreated mouse aged 6 months. Follicles in various stages of develop-
ment and corpora lutea are present. x 28.
FIG. 2.-Ovary of mouse aged 5i months which had received 3 months DMB treatment.
All follicles have gone, but degenerate remains of oocytes are still present. x 32.
FIG. 3.-Ovary of mouse aged 7 months which had begun DMB treatment 5 months pre-
viously. Few degenerate oocytes remain, corpora lutea are fused and traces of hyalinisa-
tion are present. x 28.
FIG. 4.-Ovary of mouse which had begun DMB treatment 7 months earlier. There is a
marked degree of hyalinisation of lutein tissue. x 28.
Fig. 5 to 8 show lesions suspected of being early granulosa-celled tumours.
FIG. 5. Ovary ofmouse which had begun DMB treatment 4 months earlier. Amongsteosino-
philic lutein tissue, a small nodule of more basophilic cells is seen. A larger separate nodule
was found in this ovary. Vaginal smears were oestrus. x 60.
FIG. 6.-Same nodule as Fig. 5 under greater magnification. Nuclei of many of the cells
show prominent nucleoli and nuclear membrane, typical of larger tumours (see Fig. 12).
Granulosa cells of normal follicles have nuclei which stain intensely with haematoxylin
and in which no structure can be seen. x 120.
FIG. 7.-Part of a diffusely luteinised ovary containing the smallest suspected tumour nodule
found. Five months after DMB treatment began. Vaginal smears anoestrus. x 60.
FIG. 8.-Same nodule as Fig. 8. The cells show a whorled arrangement with fibroblasts
separating them and more basophilic cytoplasm than surrounding lutein tissue. This
whorled arrangment is typical of some of the undoubted early tumours seen in these hybrid
mice. X 120.
Fig. 9 to 12 show ovaries entirely made up of tumour and undergoing luteinisation.
FIG. 9. Small ovarian tumour from a mouse killed 7 months after first DMB treatment. A
portion of the tumour is still granulosa-celled, but the greater part of it is considerably
luteinised. Vaginal smears oestrus. x 28.
FIGa. 10.-A luteinised area from the same tumour as Fig. 9. Some of the luteinised cells are
pigmented. x 120.
FIG. 11.-Part of a large ovarian tumour found 8 months after DMB treatment began. Cells
ofundifferentiated granulosa-celled tumour in nodules are surrounded by areas of luteinised
tumour cells. Vaginal smears oestrus. x 28.
FIG. 12.-Part ofFig. 11 at higher magnification. Cells typical ofundifferentiated granulosa-
celled tumour can be seen adjacent to heavily luteinised tumour cells. x 120.
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diffusely luteinised, with a small pseudofollicular granulosa-celled tumour in it.
Vaginal smears were predominantly oestrus.
The other 3 mice had atrophied ovaries. These were all diffusely luteinised,
with pigmented cells and prominent germinal epithelium. In 1 case, the latter
was invaginated, and there was slight invasion of the ovaries by lymphocytes.
In another very small ovary, there were clusters of anovular follicules and an
invaginating germinal epithelium. Both of these mice had predominantly
dioestrus smears. The 3rd had a small granulosa-celled tumour in 1 ovary and a
suspected tumour nodule in the other. Its smears were anoestrus.
-u=11-17x-17.6
FIG. 13.-Increase of detectable neoplastic changes in ovaries of DMB-treated mice with time.
Ovarian tumour incidence and survival.-The incidences of granulosa-celled
tumours which occurred in the different groups of mice is given in Table I. The
incidence has been plotted against survival time in Fig. 13 and it can be seen that
TABLE I.-Incidence of Granulosa-celled Ovarian Tumours
by Size per Month since 1st DMB Treatment
Months
since
1st
DMB
0
1
2
3
4
5
6
7
8
Total
mice
5
10
10
10
10
14
11
14
6
Without
tumours
5
10
10
9
6
5
6
3
2
Histo-
Suspected logically
tumour detected
nodules tumours
0 . 0
0 . 0
0 . 0
0 . 1
1 . 0
2 . 2
1 . 2
1 . 2*
1* . 1*
Tumours
in
unequal
ovaries
0
0
0
0
3
4
2
4*
0
Turnours
in
enlarged
ovaries
0
0
0
0
0
1
0
5
3
Mice
with
ovarian
tumours
(per cent)
o (0)
o (0)
o (0)
1 (10)
3 (30)
7 (50)
4 (36)
10 (70)
4 (67)
Total . 90
* Bilateral tumours.
t Excluding suspected tumour nodules.
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there is a roughly linear increase of incidence with time. The regression line and
its 95 per cent confidence limits are shown on the figure.
Table II summarises month by month the main histological structures found
in the ovaries ofthe C57 B1 x IF hybrid mice treated with DMB.
TABLE II.-Structures Present in Ovaries ofF1 Hybrid C57Bl x IF Mice
Treated with DMB
Ovarian tumours
Corpora lutea Partly
Months ,- -- - Sus- Granulosa- lutein-
DMB Follicles Separate Fused Hyaline pected celled ised
0 . ++ . ++ - . -
1 . ++ . + + - -
2 . + . + + . ± - -
3 . . + + - . - -
4 . - ++ + - +
5 - - ++ + . + ++ -
6 . - . - ++ + . + +
7 . - . - + + . + +
8 -- . - + - + +
+ + Abundant. + Present. - Sometimes present, sometimes absent. - Absent.
Breast tumours
Breast tumours occurred after the 4th month from the beginning of DMB
treatment. After the 5th month, many of the mice had more than 1 palpable
tumour when killed. Table III gives the numbers of tumours developed per
mouse and the incidence of mice with palpable breast tumours.
TABLE III.-Incidence of Mice with Palpable Breast Tumours
per Month Since First DMB Treatment
Number of palpable breast
tumours per mouse Mice with
Months Total A breast tumours
DMB mice 1 2 3 4 5 (per cent)
0-4 . 50 . 0 0 0 0 0 0 (0)
5 . 14 . 9 1 0 0 0 . 10(71)
6 . 11 . 4 3 2 0 0 . 9(82)
7 14 . 3 6 0 2 2 . 13(93)
8 6 . 1 1 4 0 0 . 6(100)
Over 40 breast tumours were examined histologically. They were adenocar-
cinomas, often of a papillary type, and frequently with a marked fibroblastic
component. A little secretion in the tubules was generally present. Squamous
metaplasia was seen in a few tumours, but it was very small in amount. Slight
sebaceous metaplasia was sometimes seen.
Table IV, V and VI show the relationship between the presence of ovarian
secretion (as judged by vaginal smears about the time ofdeath), ovarian tumours
(including suspected tumours) and palpable breast tumours. X2 tests on the
data ofthese tables show a significant correlation between the presence of ovarian
tumours and the secretion of ovarian hormones, but not between ovarian tumours
and breast tumours, or between breast tumours and ovarian secretion. OnlyOVARIES OF MICE TREATED WITH DIMETHYLBENZANTHRACENE 659
TABLE IV.-Relative Incidence ofBreast and Ovarian Turnours in
45 C57 Bi x IF mice Treated with DMB
Breast tumours
+ - Totals
Ovarian tumours + . . 27 3 . 30
- . . 11 4 . 15
Totals . . . 38 7 . 45
x2 =2-593. P > 01.
TABLE V.-Relation between Presence of Ovarian Tumours and Ovarian Secretion
as Judged by Vaginal Smears in 42 C57 Bl x IF Mice Treated with DMB
Vaginal smears
Oestrus or
dioestras Anoestrus Totals
Ovarian tumours . . 21 8 . 29
- . . 3 10 . 13
Totals . . . 24 18 . 42
-2 8 9. P about 0 003.
TABLE VI.-Relation between Presence of Ovarian Secretion and Breast Tumours in
42 C57 Bi x IF Mice Treated with DMB
Vaginal smears
r -,
Oestrus or
dioestrus Anoestrus Totals
Breast tumours ± . 22 13 35 -- . . 2 5 . 7
Totals . . . 24 18 . 42
X2 -2-224. Pabout 0 12.
mice which survived over 4 months are included, because breast tumours were
not apparent before this time.
DISCUSSION
Ovarian grafting-experiment
It will be seen from Table I that, in the 10 mice killed 3 months after the first
DMB painting, only 1 early tumour was found in serial sections of all 20 ovaries.
We may be fairly sure, then, that detectable incipient ovarian tumours were
present in very few of such ovaries transplanted to the 18 mice in the original
experiment (Marchant, 1959a). However, the fact that 14 of them (78 per cent)
developed large ovarian tumours indicates that changes leading towards tumour
production had already occurred in the majority of ovaries after 3 months treat-
ment. The present histological study showed no evidence of any form of hyper-
plasia, but rather of ovarian atrophy brought about by follicular destruction with
accompanyingreduction in numbers ofcorpora lutea. In a more recent experiment
the mean weight of ovaries from normal young adult F1 C57B1 x IF mice wasJUNE MARCHANT
found to be 9.8 mg., while that of ovaries removed 3 months after commencing
DMB treatment was only 4 mg.
The fact that few really large ovarian tumours were found in the present
experiment is undoubtedly due to the time factor involved. Breast tumours
developed in rapidly increasing numbers after 41 months of treatment and this
made itnecessary to kill all animals by the 8th month. In the original experiment
(Marchant, 1959a) the ovaries grafted from DMB treated to normal animals after
3 months of treatment were able to survive a further 14 months in their new
hosts, allowing ample time to grow into really large tumours.
Histogenesis of ovarian turnours
When we consider the histogenesis of the granulosa-celled tumours, it seems
impossible to say what type of tissue the tumours originated from. Fig. 13
shows that ovarian tumours steadily continued to appear after 3 months DMB
treatment, although by 4 months no follicles remained in any ovaries. It would
seem that tumours which arose after 4 months treatment could not have arisen
from follicular tissue.
There was no evidence of origin of the granulosa-celled tumours from down-
growth and invagination ofgerminal epithelium, such as precedes the appearance
of tubular adenomas, described by Russell and Fekete (1958). The prominence
of germinal epithelium and slight invagination of it was only occasionally seen
in the late stages of the experiment and seemed to be associated with ovarian
atrophy.
It is possible that the tumours may have arisen from stem cells in the ovarian
parenchyma, a view held by Willis (1953) and others.
Luteinisation ofgranulosa-celled tumours
From a study of the tumours in this and other experiments (Marchant, 1959b)
with ovaries from DMB-treated mice, it seems quite clear that luteomas arise
from pre-existing granulosa-celled tumours. At the time when granulosa-celled
tumours are first detected, the ovaries are usually in a diffuselyluteinised condition
resulting from fusion of corpora lutea, with fusion and vacuolation of their cells.
This diffusely luteinised tissue somewhat resembles that of a granulosa-celled
tumour that has undergone a marked degree of luteinisation. Thus, on seeing
a diffusely luteinised ovary containing an incipient granulosa-celled tumour, one
might be tempted to assume that granulosa-celled tumours arise in pre-existing
luteomas. That this is not the case can only be determined by study of a series
of animals killed at intervals of time throughout the induction period. The
series described here has shown that ovaries in a diffusely-luteinised condition
are atrophied and do not grow in size, in fact mitosis has never been observed
in a luteinised cell.
The luteinisation of granulosa-celled tumours was not seen in IF or C57 B1
mice (Marchant, 1957), but it was very marked in the grafting experiment already
mentioned (Marchant, 1959a) utilising F1 C57 B1 x IF mice. It was also seen
in the later stages ofan experiment in which IF or C57B1ovaries weretransplanted
into C57 B1 x IF hosts prior to DMB-treatment (Marchant, 1959b). It may be
that luteinisation is a matter of maturation of the tumour cells, or it may be
brought about by some factor in the internal environment of the hybrid mice
differing from that in the parent strains.
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IHyalinisation
"Hyalinisation" of corpora lutea was a phenomenon not previously en-
countered in ovaries of C57 B1 mice treated with DMB and only rarely in mice
with IF ovaries (Howell, Marchant and Orr, 1954). It was frequently seen in
these C57 B1 x IF hybrid ovaries as in old dba mice (Fekete, 1946) and in dba
x CE hybrid mice (Atkinson et al., 1954).
Hormoneproduction by ovarian tumours
Secretion of oestrogen, as judged by vaginal smears, was seen in 21/29 (72
per cent) of animals with ovarian tumours (Table V). This is comparable with
the 39/48 (81 per cent) found in the previous report of ovarian tumours in IF
or IF hybrid mice (Howell, Marchant and Orr, 1954) and indicates that approxi-
mately 1 out of4 or 5 granulosa-celled tumours in mice does not secrete oestrogen.
Breast tumours
The DMB treatment induced breast tumours in the majority ofmice surviving
more than 4 months. There was no correlation between the presence of breast
tumours and oestrogen secretion at the time of death, as shown by Table VI.
SUMMARY
Eighty-five virgin female F1 hybrid mice between C57 B1 and IF strains were
used. They were given up to 6 fortnightly skin paintings of 1 mg. DMB in olive
oil in order to induce ovarian tumours. As far as possible, 10 mice were killed
at monthly intervals and their ovaries sectioned and examined histologically.
The first change noticed in all ovaries was a gradual diminution in numbers of
follicles until all had disappeared by the 4th month. Corpora lutea became
fused, until by the 4th month there were rarely any distinct ones to be found.
After this, lutein tissue showed considerable variation with frequent vacuolation
and pigmentation of cells. Sometimes it became converted to collagenous tissue
resembling human corpora albicantia. As a result of these changes the ovaries
atrophied in size.
Incipient granulosa-celled tumours were found from the 3rd month onwards.
They were usually unilateral and were detected in a steadily increasing proportion
of animals. About three-quarters of the tumours secreted oestrogen, as judged
by vaginal smears. In the later stages the tumour cells showed traces of luteini-
sation.
There was a gradual increase in numbers of palpable breast tumours after the
4th month.
The author is grateful to the Birmingham Branch ofthe British Empire Cancer
Campaign for support of this work.
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